IPHA
Innate Pharma
IPHA
IPHA
11 hedge funds and large institutions have $483K invested in Innate Pharma in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$179K | |
| 2 | +$157K | |
| 3 | +$54.9K | |
| 4 |
Millennium Management
New York
|
+$39.2K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$9.14K |
Top Sellers
| 1 | -$39.1K | |
| 2 | -$13.8K | |
| 3 | -$7.43K | |
| 4 |
GI
GAMMA Investing
Foster City,
California
|
-$2.33K |
| 5 |
Barclays
London,
United Kingdom
|
-$591 |